Innovative Medicine Database

Disclaimer: The website is intended solely for facilitating non-profit research and development in relation to medical and healthcare related policies. (Last update on: 24 Oct 2024)

Unlock The Innovative Medicines Of Tomorrow

The Innovation Medicine Database is an evolving pilot platform highlighting breakthrough treatments across three key therapeutic areas, based on early and landmark trials, serving as a foundation to help build future information systems for medical innovation.
{{ disease.title }}
Active Substance
Brand Name
Drug Class
Phase of Study
HK Drug Office Status
FDA
EMA
NMPA
Active Substance
Abbreviations

Anti-IL: Anti-interleukin; JAK: Janus kinase; PARP: Poly ADP-ribose polymerase; NMDA: N-methyl-D-aspartate; NMBA: Neuromuscular Blocking Agent; GABA: Gamma-aminobutyric acid; S1P: Sphingosine-1-phosphate; TNF: Tumor Necrosis factor; TLR: Toll-like receptor.